|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Prostate cancer in Asia:A collaborative report显示文摘The incidence of prostate cancer(PCa)within Asian population used to be much lower than in the Western population;however,in recent years the incidence and mortality rate of PCa in some Asian countries have grown rapidly.This collaborative report summarized the latest epidemiology information,risk factors,and racial differences in PCa diagnosis,current status and new trends in surgery management and novel agents for castration-resistant prostate cancer.We believe such information would be helpful in clinical decision making for urologists and oncologists,health-care ministries and medical researchers. | Rui Chen Shancheng Ren 无 Ming Kwong Yiu Ng Chi Fai Wai Sam Cheng Lap Hong Ian Seiji Naito Tadashi Matsuda Elijah Kehinde Ali Kural Jason Yichun Chiu Rainy Umbas Qiang Wei Xiaolei Shi Liqun Zhou Jian Huang Yiran Huang Liping Xie Lulin Ma Changjun Yin Danfeng Xu Kexin Xu Zhangqun Ye Chunxiao Liu Dingwei Ye Xin Gao Qiang Fu Jianquan Hou Jianlin Yuan Dalin He Tiejun Pan Qiang Ding Fengshuo Jin Benkang Shi Gongxian Wang Xiuheng Liu Dongwen Wang Zhoujun Shen Xiangbo Kong Wanhai Xu Yaoliang Deng Haibo Xia Alexa NCohen Xu Gao Chuanliang Xu Yinghao Sun | 2014 | Asian Journal of Urology2014，1，1： | 13 |
| 2 | 恩度肝动脉灌注联合介入化疗栓塞治疗中晚期肝癌的临床观察(英文)显示文摘Objective:To study the efficacy and safety of hepatic arterial infusion of Endostatin(YH-16,Endostar),combined with transcatheter arterial chemoembolization(TACE) on advanced hepatocellular carcinoma.Methods:Thirty patients with advanced hepatocellular carcinoma were enrolled in the study.The patients received hepatic arterial infusion of Endostar combined with TACE.The efficacy was evaluated strictly after 1-2 cycles according to RECIST criteria and the value of AFP;quality of life(QOL) was evaluated according to Karnofsky scores.Adverse effects were evaluated too.Results:29 cases' efficacy was evaluated among the total 30 cases.The KPS were significantly increased after the treatment(80.39 ± 8.37 vs 73.93 ± 9.22,P = 0.002).Compared with control group,the objective response rate(CR and PR) and the rate of AFP negative changed were significantly higher(P = 0.021,P = 0.046).The adverse effects were not obvious.Conclusion:The QOL and preliminary efficiency of patients of advanced hepatocellular carcinoma may be improved by hepatic arterial infusion of Endostar combined with TACE,the rate of AFP negative changed were significantly higher too,and there are little of adverse effects.It is worthy to clinical generalization and further clinical observation. | Xiuheng Qi Zhenming Wu Qi Liu Shiyu Yu | 2008 | The Chinese-German Journal of Clinical Oncology2008，7，10： | 2 |
| 3 | Assessment of antibiotic prescription in hospitalized patients at a Chinese university hospital显示文摘 | Suping Hu Xiuheng Liu Yan Peng | 2003 | J Infect2003，46，3： | 1 |
| 4 | Assessment of Antibiotic Prescription in Hospitalised Patients at a Chinese University Hospital显示文摘 | Suping Hu Xiuheng Liu Yan Peng | 2003 | Journal of Infection2003，，3： | 1 |
| 5 | At tenuation of reperfusion injury by renal ischemic post- conditioning: the role of NO显示文摘 | LIU Xiuheng CHEN Hui ZHAN Bingyan | 2007 | Biochem Biophys Resb Commun2007，359，： | 1 |
| 6 | Attenuation of reperfusion injury by renal ischemic postconditioning: The role of NO显示文摘 | Xiuheng Liu Hui Chen Bingyan Zhan Bianzhi Xing Jiangqiao Zhou Hengcheng Zhu Zhiyuan Chen | 2007 | Biochemical and Biophysical Research Communications2007，，3： | 1 |
| 7 | Ischemic Postconditioning Inhibits Apoptosis After Focal Cerebral Ischemia/Reperfusion Injury in the Rat显示文摘 | Bianzhi Xing Hui Chen Min Zhang Dongming Zhao Rui Jiang Xiuheng Liu Suming Zhang | 2008 | Stroke2008，，8： | 1 |
| 8 | Study of hepatic arterial infusion ofEndostar combined with TACE on advanced hepato Celluar Carcinoma显示文摘 | Xiuheng Oi Zhenming Wu Oj Liu | 2008 | Chinese-German J Clin Oncol2008，7，10： | 1 |
| 9 | Ischemic Postconditioning Attenuates Renal Ischemic/Reperfusion Injury in Mongrel Dogs显示文摘 | Botao Jiang Xiuheng Liu Hui Chen Dongshan Liu Youling Kuang Bianzhi Xing Zhiyuan Chen | 2010 | Urology2010，，6： | 1 |
| 10 | The second short-term warm ischemia after vascular anastomosis did not affect early renal function recovery in renal transplantation:a case report显示文摘Ischemic postconditioning was defined as rapid intermittent interruptions of blood flow in the early phase of reperfusion,which has been found to be protective against renal ischemia-reperfusion injury(IRI)in animal models but not in clinical trials.We describe a case that the allograft renal vein was twisted because of the surgeon’s mistake,which caused the warm ischemia of allograft after reperfusion.The allograft restored blood flow without second reperfusion and cold preservation after 9 min of warm ischemia.The patient was followed up for 3 months and the allograft worked well without complications. | Tao Qiu Jiangqiao Zhou Xiuheng Liu Minghuan Ge Zhiyuan Chen | 2012 | Frontiers of Medicine2012，6，3： | 0 |
| 11 | Real-world effectiveness and safety of goserelin 10.8-mg depot in Chinese patients with localized or locally advanced prostate cancer显示文摘Objective:Real-word data on long-acting luteinizing hormone-releasing hormone(LHRH)agonists in Chinese patients with prostate cancer are limited.This study aimed to determine the real-world effectiveness and safety of the LHRH agonist,goserelin,particularly the long-acting 10.8-mg depot formulation,and the follow-up patterns among Chinese prostate cancer patients.Methods:This was a multicenter,prospective,observational study in hormone treatment-na?ve patients with localized or locally advanced prostate cancer who were prescribed goserelin 10.8-mg depot every 12 weeks or 3.6-mg depot every 4 weeks with or without an anti-androgen.The patients had follow-up evaluations for 26 weeks.The primary outcome was the effectiveness of goserelin in reducing serum testosterone and prostate-specific antigen(PSA)levels.The secondary outcomes included testosterone and PSA levels,attainment of chemical castration(serum testosterone<50 ng/d L),and goserelin safety.The exploratory outcome was the monitoring pattern for serum testosterone and PSA.All analyses were descriptive.Results:Between September 2017 and December 2019,a total of 294 eligible patients received≥1 dose of goserelin;287 patients(97.6%)were treated with goserelin 10.8-mg depot.At week 24±2,the changes from baseline[standard deviation(95%confidence interval)]in serum testosterone(n=99)and PSA(n=131)were-401.0 ng/d L[308.4 ng/d L(-462.5,-339.5 ng/d L)]and-35.4 ng/m L[104.4 ng/m L(-53.5,-17.4 ng/m L)],respectively.Of 112 evaluable patients,100(90.2%)achieved a serum testosterone level<50 ng/d L.Treatment-emergent adverse events(TEAEs)and severe TEAEs occurred in 37.1%and 10.2%of patients,respectively.The mean testing frequency(standard deviation)was 1.6(1.5)for testosterone and 2.2(1.6)for PSA.Conclusions:Goserelin 10.8-mg depot effectively achieved and maintained castration and was well-tolerated in Chinese patients with localized and locally advanced prostate cancer. | Nanhui Chen Zengjun Wang Ming Chen Qi Ma Yi He Yujie Wang Xin Li Mingxing Qiu Lei Shi Shaoxing Zhu Qun Xie Xiuheng Liu Benkang Shi Guowen Lin Weizhong Yang Yongbin Liao Haibin Zhang Shusheng Wang Jiexian Li Shaogang Wang Lijun Dong Hui Chen Jiaju Lu YongyiCheng Xiaoping Zhang Lulin Ma Liqun Zhou He Wang Shen Li Dingwei Ye | 2023 | Cancer Biology & Medicine2023，20，12： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员